Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
2.
Kidney Int ; 36(1): 120-6, 1989 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-2572718

RESUMEN

Parathyroidectomy (PTx) is indicated in hemodialysis (HD) patients who have severe osteitis fibrosa unresponsive to vitamin D therapy or in whom the latter treatment is contraindicated. Immediately after PTx, plasma immunoreactive parathyroid hormone, calcium and phosphorus concentrations decline abruptly. However, little is known in such patients about the short-term effects of PTx on plasma alkaline phosphatase (AP) activity and plasma aluminum (Al) levels. The present, preliminary study was performed to determine such parameters in 37 HD patients, and to correlate them with data of bone histology. Mean plasma AP activity started to increase after PTx from day 4 onwards. Thus, AP values significantly higher than pre-PTx values were observed at day 7 and 14 (415 +/- 54 vs. 619 +/- 77 and 749 +/- 83 IU/liter, means +/- SEM; N = 37; P less than 0.05 and 0.001, respectively). This increase, in the absence of changes in liver function, was mainly due to the bone-specific iso-AP. Moreover, the degree of increase in plasma AP activity was higher in the subgroup with negative (group I, 21 patients) than in that with positive bone Al staining (group II, 16 patients). However, plasma osteocalcin (BGP) did not change after PTx (N = 8). Basal plasma Al levels were significantly higher in group II both before and two weeks after surgery.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Hiperparatiroidismo Secundario/cirugía , Glándulas Paratiroides/cirugía , Uremia/sangre , Fosfatasa Alcalina/sangre , Aluminio/sangre , Huesos/patología , Calcifediol/sangre , Calcio/sangre , Enfermedad Crónica , Estudios de Cohortes , Deferoxamina , Humanos , Hiperparatiroidismo Secundario/sangre , Osteocalcina/sangre , Hormona Paratiroidea/sangre , Fósforo/sangre , Diálisis Renal/efectos adversos , Factores de Tiempo , Uremia/complicaciones , gamma-Glutamiltransferasa/sangre
3.
Nephron ; 46(1): 18-22, 1987.
Artículo en Inglés | MEDLINE | ID: mdl-3299116

RESUMEN

Severe, prolonged hypocalcemia in observed in some, but not all, hemodialysis patients after parathyroidectomy performed because of uncontrolled hyperparathyroidism. The aim of the present study was to investigate whether calcitriol and calcium supplementation in the immediate period after parathyroidectomy (days 1-14) was of more help in the control of plasma calcium than calcium supplementation alone. Fourteen hemodialysis patients were enrolled in a prospective, randomized, double-blind and placebo-controlled study. From the day after parathyroidectomy, 7 patients received calcitriol and the remaining 7 a placebo using incremental doses adjusted to the degree of hypocalcemia (up to 4 micrograms/day for calcitriol). Plasma calcium, phosphorus, alkaline phosphatase and immunoreactive parathyroid hormone levels before parathyroidectomy were comparable in both patients groups, as was the lowest plasma calcium achieved after parathyroidectomy. The decrease in plasma calcium after parathyroidectomy was related to plasma alkaline phosphatase and to the number of osteoclasts and osteoblasts on bone biopsy surface before parathyroidectomy. The mean decrement of plasma calcium (days 3-9) as compared to that before parathyroidectomy was less pronounced in calcitriol-treated than in placebo-treated patients (0.25 +/- 0.06 versus 0.45 +/- 0.05 mM, mean +/- SEM, p less than 0.025). Treatment with placebo was interrupted before day 14 because of persistent severe hypocalcemia in 4 of 7 patients, whereas calcitriol treatment was continued in all 7 patients up to 14 days. Patients on calcitriol treatment required less mean calcium supplements (days 1-9) than patients receiving placebo (37.4 +/- 3.2 versus 49.4 +/- 3.7 g, p less than 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Calcitriol/uso terapéutico , Hiperparatiroidismo Secundario/cirugía , Hipocalcemia/tratamiento farmacológico , Complicaciones Posoperatorias/tratamiento farmacológico , Diálisis Renal , Ensayos Clínicos como Asunto , Método Doble Ciego , Humanos , Hipocalcemia/etiología , Placebos , Estudios Prospectivos
4.
Am J Kidney Dis ; 3(5): 366-70, 1984 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-6702823

RESUMEN

Following earlier studies using a simplified cryopreservation method in rats, we report the successful use of this technique in a hemodialysis patient who had previously undergone total parathyroidectomy. In additional studies, parathyroid glands from rats were conserved by this rapid freezing procedure after total parathyroidectomy. Six weeks after parathyroid autotransplantation the animals were submitted to a low-calcium diet and their parathyroid gland function compared to that of rats that had previously undergone sham operation, immediate autotransplantation, or delayed autotransplantation using the classical cryopreservation method. With both cryopreservation techniques, plasma calcium, phosphorus, and 1,25 (OH)2 vitamin D concentrations after low-calcium diet were similar although results were less satisfactory than with immediate autotransplantation or after sham operation. We suggest that this simplified cryopreservation technique, developed in rats, yields functioning parathyroid gland tissue and can be successfully used in the human.


Asunto(s)
Hiperparatiroidismo/terapia , Glándulas Paratiroides/trasplante , Adulto , Animales , Calcio/sangre , Femenino , Congelación , Humanos , Hiperparatiroidismo/sangre , Hiperparatiroidismo/etiología , Glándulas Paratiroides/cirugía , Fósforo/sangre , Ratas , Ratas Endogámicas , Diálisis Renal/efectos adversos , Factores de Tiempo , Conservación de Tejido , Trasplante Autólogo , Uremia/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA